Paper Title
Psychosocial and Occupational Improvement in Treatment of Major Depressive Disorder (MDD) with Vortioxetine: With Case Study

Abstract
Major depressive disorder (MDD) is a burdensome condition comprising of emotional, physical and cognitive symptoms. In addition to negatively impacting patient quality of life, the socioeconomic burden associated with depression is substantial, driven by work productivity losses. The use of anti-depressant medications has been the mainstay for treating individuals suffering from depression. Although many antidepressants demonstrate a similar response across most domains, their key difference lie in their effect on cognitive symptoms. Vortioxetine (Trintellix) has a unique multimodal mode of action, which works through a combination of two mechanisms of action: receptor activity modulation and reuptake inhibition that improves depressive symptoms independent of improving cognitive functioning. In this article, we will highlight the effects of Vortioxetine and how it improves depressive symptoms independent of improving cognitive functioning. We will also present a case study which demonstrates Vortioxetine’s duel approach in improving the quality of life of MDD patients. Index Terms - Cognitive Function, Major Depressive Disorder, Vortioxetine, Trintellix